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The ~68 Ca*+ and phospholipid binding protein of the lipocortin/calpactin family appears to exist as two forms. These may be resolved into a 
closely-spaced polypeptide doublet by SDS-PAGE. The cloning and sequencing of p68 revealed an apparent 18 nucleotide alternative splice se- 
quence, which could account for this observation. We show here that an antiserum directed against a synthetic peptide corresponding to the region 
containing the splice sequence, recognises only the upper band of the p68 doublet by both immunoprecipitation and Western blotting., These results 
arc consistent with alternative splicing being responsible for the generation of the two forms of ~68. 
~68; Ca*+-binding protein; Lipocortin; Calpactin; Alternative splicing 
1. INTRODUCTION 
The lipocortin/calpactin family of Ca2+ and 
phospholipid binding proteins is now known to com- 
prise at least 8 different members, as judged by cDNA 
sequence analysis. Although the functions of these pro- 
teins are not well understood (with the possible excep- 
tion of synexin which exhibits Ca*+-channel activity 
[l]), several diverse properties have been ascribed to 
them, such as inhibition of phospholipase AZ, inhibi- 
tion of blood coagulation, actin-binding and collagen- 
binding (for reviews see [2,3]). The largest member of 
the family, namely p68 (MT = 68 000) (67 kDa calelec- 
trin) was first identified in Ca*+-dependent association 
with the detergent insoluble residue of B-lympho- 
blastoid plasma-membrane [4]. The protein invariably 
appears on denaturing gel electrophoresis as a closely- 
spaced polypeptide doublet, frequently with the upper 
band heavier than the lower. Molecular cloning reveal- 
ed that p68 comprised 8 repeats of the 64 amino acid 
consensus equence which both typifies and defines the 
lipocortin/calpactin family of proteins [5-71. The other 
7 related proteins, namely protein II, lipocortin I, 
calpactin I, endonexin II, lipocortin II, synexin and 
VAC-fl, have molecular weights in the range 
32000-47 000, each containing 4 of the internally 
repeated sequence motifs. Although the proteins are 
closely related by virtue of their sequence similarities, 
each has a unique N-terminal sequence which it has 
been proposed may confer functional individuality [2]. 
The sequence analysis of both human [5] and murine 
p68 [6] revealed an apparent alternative splice sequence 
of 18 nucleotides, encoding the hydrophobic hexapep- 
tide Val-Ala-Ala-Glu-Ile-Leu (VAAEIL), close to the 
start of the seventh repeat. Alternative splicing of a 
single primary RNA transcript, which would give rise to 
two protein species differing by 6 amino acids, would 
provide both a convenient and plausible explanation for 
the characteristic p68 doublet observed on SDS-PAGE. 
To test the alternative splice theory as the mechanism 
for the origin of the two p68 species, rabbits were im- 
munised with a synthetic DAQVAAEILEIC peptide 
conjugated to thyroglobulin, and the derivative antisera 
were used to investigate whether this sequence was uni- 
que to the upper band of the p68 doublet. 
2. MATERIALS AND METHODS 
2.1. Antisera 
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A rabbit anti-(human ~68) immunoglobulin G (IgG) fraction 
(MC2) was prepared by standard methods [9] from a polyclonal an- 
tiserum of known specificity described previously [5], raised against 
purified denatured human tonsil ~68. A control IgG fraction was 
prepared in the same way using pre-immune serum from the same 
rabbit. 
A second antiserum (SS3) was generated by immunisation of rab- 
bits with a synthetic DAQVAAEILEIC peptide (P) coupled via the C- 
terminal cysteine to thyroglobulin (P-TG). Since the actual proposed 
splice-sequence (VAAEIL) is small, it was considered that the inclu- 
sion of some flanking amino acids would improve the chances of 
creating an antigenic determinant. A peptide corresponding to the 10 
N-terminal amino acids of human p68 coupled to thyroglobulin (N- 
TG), was used as a control in one experiment. Both peptides were 
kindly prepared by Dr J. Rothbard (ICRF). Rabbits were injected at 
multiple sites subcutaneously with 1 mg of P-TG in Freunds complete 
adjuvant. The rabbits were immunised again after 4 weeks using 1 mg 
P-TG in Freunds incomplete adjuvant, and bled 10 days later. Cycles 
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of re-immunisation followed by test bieeds were continued as re- 
quired, and serum from each bleed was stored aliquoted at - 20°C. 
For affinity purification of SS3, an IgO fraction was first prepared 
from 50 ml antiserum [9], and this was passed over a column of 
peptide-bovine serum albumin conjugate (P-BSA), immobilised on 
CNBr-activated Sepharose 4B (Sigma Chemical Co. UK). Bound an- 
tibody was eluted with 3 M KSCN in 0.5 M N&OH, dialysed against 
ice-cold 10 mM sodium phosphate buffer, pH 7.4, containing 0.15 M 
NaCl (PBS), and concentrated to 1.85 m&ml (total yield = 2 mg IgG 
from 50 ml serum). Afiquots were stored at - 70°C. 
The human T-Ieukaemia cell-line 36 was routinely maintained in 
RPM1 1640medium containing 5% (v/v) foetal calf serum (F&S). For 
metabolic labeiiing, cells were first transferred to methionine-free 
RPM1 1640 medium containing 5% (v/v) dialysed FCS, for 1 h, to 
deplete the intracellular pool of methionine. This was followed by in- 
cubation in the same medium containing SO pCi/ml [‘?+]methionine 
(600 Ci/mmol, Amersham PLC, UK) for 4 b at 37OC. Prior to lysis, 
cells were washed twice with ice-cold PBS. 
2.3. Immunoprec~piiation: SDS-PAGE and Western blotting 
Metabolically iabelled ceils were grown as described, and lysed (lo7 
cells,‘ml) in 10 mM Tris-HCI buffer, pH 7.4, containing 50 mM NaCl, 
I% (Y/V) Nonidet P-40, 5 mM ~amin~t~an~~raacetjc acid (ED 
?“A), 1 mglml BSA and 1 mM phenyimetb~lsuIphony~~uoride 
(PMSF), for 2 min on ice. Lysates were centrifuged at lOO@O x g for 
10 min at 4OC to remove nuclei and membranes, and supernatants 
were retained for immunopreejp~tat~o~. Lysates were adjusted to give 
final concentrations of sodium dodecyl sulphate (SDS) as indicated in 
the figure legends. 
Immunoprecipitation was achieved by the addition of MC2 (1Opg 
Kg0 fraction/lo6 cell equivalents) or SS3 (10 pg affinity-purified 
lgO/106 cell equivalents). Note: the quantities of MC2 and SS3 used 
in these experiments were determined empirically, and the relatively 
high amount of SS3 (affinity-purified X&l) required probably reflects 
the low affinity of this antibody compared to that of MC2 (total igG). 
Samples were maintained on ice for 60 min prior to the addition of 50 
pf 10% (w/v) protein A-Sepharose (Pharmacia, Sweden) in PBS eon- 
taining 0.02% (w/v) NaNs, Sampfes were mixed by rotation at 4°C 
for 30 min, briefly pelleted by centrifugation, washed twice with 1 ml 
ice-cold PBS, and finally resuspended in 80 mM Tris-HCI buffer pH 
6.8 containing 4% (w/v) SDS, 4% (v/v) glycerol, 4% (v/v) 
2-mercaptoethanol and 0.02”/0 (w/v) Bromophenof blue, heated at 
95VZ for 5 min and subjected to SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) [lo]. Preadsorption of antisera was per- 
formed by incubating aliquots of SS3 (10 ,zg IgG) with saturating 
quantities of either free peptide (5/c& or peptide-conjugate (1Opg) on 
ice for 30 min. 
Western blotting was performed by the method of Towbin et al. 
[l 11, and colour development of nitrocellulose filters was achieved us- 
ing goat anti-(rabbit IgG) IgG coupled to horseradish peroxidase 
(Tago Inc. USA) with 4-chloronaphthol as colour reagent. 
3. RESULTS 
In order to determine the specificity of antiserum 
SS3, a combination of Western blotting and im- 
munoprecipitation experiments were performed, in 
conjunction with antiserum MC2. The model being 
tested is shown in fig. 1, which illustrates schematically 
the proposed structures of the two bands of the p68 
doublet. The results in fig.2 (panels A and B), show that 
both antisera demonstrated SDS-dependent im- 
munoprecipitation of f35SImethionine labelled ~68, 
from 56 cells. MC2 was found to be capable of im- 
munopr~ipita~ng p68 at SDS levels ranging from 
0.1% to I .O%, whereas 553 was most effective at 0.2% 
to OS%. Significantly, SS3 which was raised against he 
peptide corresponding to the ~68 alternate splice se- 
quence, immunoprecipitated a single polypeptide at 68 
kDa, whereas MC2 which was raised against the whole 
protein, immunoprecipitated the characteristic 68 kDa 
doublet. Non-specific precipitation of other bands was 
observed, although for MC2 these were also repre- 
sented in the pre-immune serum tracks (fig,Z, panel A). 
Considerably more background bands were observed 
with SS3 (fig.2, panel B), although with increasing SDS 
concentration, these di~~shed whereas only the 68 
kDa band exhibited increased intensity. 
Fig.2, panel C shows that he 68 kDa band im- 
munoprecipitated with SS3 migrated with the same 
mobility as the upper band of the MC2 p68 doublet. 
MC2 
mp1 84 amino-acid repeated unit 
Fig. 1. Schaatic model for the proposed structures of the two forms of ~68. Both bands of the ~68 doublet are illustrated, each containing the 
8 repeated units. The position of the alternative splice sequence at the start of the seventh repeat is also indicated, but only in the upper band. 
The ~~torad~~ra~h on the right shows ~~‘SJmethion~ne-labe~l~ p6% rnrn~n~pr~~pitat~ withMC2 in the preserxe of 0.5% SDS, from a lysate 
of T-ieukaemia 36 cells, 
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Fig.2. SDS-dependent immunoprecipitation of ~68. Panels A and B show autoradiographs of [35S]methionine-labelled p68 immunoprecipitated 
with MC2 and SS3, respectively, from 56 lysates, in the presence of increasing levels of SDS. Panel C shows the effect of preadsorption of SS3 
with either P, P-TG or N-TG. The positions of molecular mass protein standards are also indicated. These were phosphorylase B (97000), BSA 
(68 000) and ovalbumin (43 000). 
Preadsorption of SS3 with either free peptide (SS3 + P) 
or peptide-conjugate (SS3 + P-TG) abrogated im- 
munoprecipitation of the 68 kDa band, whereas pread- 
sorption with a peptide corresponding to the p68 N- 
terminus (SS3 + N-TG) had no effect. These observa- 
tions indicate that the antiserum SS3 recognises a 
polypeptide which co-migrates on SDS-PAGE with the 
upper band of the p68 doublet, and that the polypeptide 
shares an antigenic determinant(s) with the peptide 
DAQVAAEILEIC. However, the upper band of the 
~68 doublet immunoprecipitated by MC2, was more in- 
tense on autoradiography than the single 68 kDa band 
produced by SS3 (fig.2, panel C). This raised the 
possibility that the apparent absence of the p68 lower 
band in the SS3 precipitates could simply be due to a 
lack of sensitivity of the technique. 
To confirm that the polypeptides recognised by these 
antisera were identical, a system of immunoprecipita- 
tion coupled to Western blotting was used, whereby the 
immunoprecipitated material generated by one an- 
tiserum was tested against the other by immunoblot- 
ting. The results in fig.3 clearly show that if p68 is im- 
munoprecipitated by MC2 (in the presence of 0.5% 
SDS), SS3 identifies only the upper band on Western 
blotting (panel A, lane 2). The alternate use of MC2 in 
the blotting stage (panel B, lane 2), confirms that both 
polypeptides were immunoprecipitated and successfully 
transferred to nitrocellulose. Conversely, when SS3 was 
used to immunoprecipitate p68 (in the presence of 0.3% 
SDS), MC2 identified only the upper band on Western 
blotting (panel B, lane 3). As expected, alternate use of 
SS3 in the blotting stage (panel A, lane 3) confirmed the 
presence of only the upper band. These findings were 
substantiated by Western blot analysis of both a 56 
whole cell lysate and purified p68 (generously provided 
by H. Edwards and W. Verbi, ICRF). In both cases, 
SS3 recognised only a single band at 68 kDa (panel A, 
A 
1 2 3 4 
0 
1 2 3 4 
Fig.3. Western blot analysis of SS3 and MC2. Panel A was im- 
munoblotted with SS3 and panel B with MC2. (Lane 1) 56 whole cell 
lysate; (lane 2) MC2 immunoprecipitate; (lane 3) SS3 im- 
munoprecipitate; (lane 4) purified placental ~68. The positions of 
prestained molecular mass markers are also indicated (see legend to 
fig.2). The heavily staining bands at approximately 50 kDa, in lanes 
2 and 3 in both panels are rabbit IgG heavy chains, arising from the 
immunoprecipitation stage, and directly detected by the second an- 
tibody (goat anti-(rabbit IgG) IgG coupled to horseradish peroxidase) 
during the blotting procedure. 
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Fig.4. Mechanisms of alternative splicing. The figure shows 
diagramatically the possible mechanisms of splicing for ~68. The con- 
stitutively expressed exons are shown as hatched boxes, and the alter- 
natively spliced sequence as a striped box. The dotted lines indicate 
possible splicing pathways (adapted from Breitbart et al. [8]). 
lanes 1 and 4, respectively), whereas MC2 recognised 
both bands (panel B, lanes 1 and 4, respectively). These 
observations demonstrate that MC2 and SS3 cross-react 
immunologically with the same polypeptide, namely the 
upper band of the ~68 doublet, but that MC2 also cross- 
reacts with the lower band. 
4. DISCUSSION 
In these studies, using an anti-(peptide) serum, we 
have provided compelling evidence that the VAAEIL 
hexapeptide sequence is unique to the upper band of the 
p68 doublet, as revealed by SDS-PAGE. From these 
results, supported by the observation that single gene 
loci were identified during the chromosomal assign- 
ments of both the human and murine p68 genes (to 
chromosomes 5 and 11, respectively) [13], it is conclud- 
ed that the two forms of ~68 arise by alternative splicing 
of a single primary RNA transcript. The 4 splicing 
models which could generate the doublet are shown in 
fig.4. The cassette model is most likely, since the alter- 
native splice sequence lies within recognised splice 
donor and acceptor sites. Of the remaining 3 models, 
the internal donor site is more probable, in view of its 
stronger conformity in nucleotide sequence to the 
donor site consensus. On the other hand, if the 
18nucleotide ~68 splice sequence is an individual exon, 
rather than a retained intron or the product of internal 
exon splicing (see fig.4), then it is amongst he smallest 
reported (the cardiac troponin T gene has a 6-nucleotide 
exon [12]). The possibility remains, albeit unlikely, that 
the two forms of ~68 are encoded by separate genes, 
differing only with respect to the sequence of 18 
nucleotides identified during cloning, lying within close 
proximity on the same chromosome, thereby defying 
resolution by in situ hybridisation. 
Alternative splicing is a well-recognised characteristic 
of eukaryotic genes, providing a sophisticated means of 
generating more than one protein product from a single 
gene [8]. Although many genes are now known to 
generate protein diversity through alternative splicing, 
~68 is the only member of the lipocortin/calpactin 
family to have been identified with this phenomenon. 
We have previously proposed that the ~68 gene may 
have arisen by duplication of a gene encoding a 4 repeat 
protein [2]. In this case, since the N-terminal half of ~68 
resembles the 4 repeat proteins more closely than the C- 
terminal half, it seems likely that the alternative splice 
sequence arose during or after the proposed gene 
duplication event. It is not yet known whether alter- 
native splicing of ~68 is functionally significant, but the 
production of antibodies which can discriminate bet- 
ween the two forms, will clearly be useful in addressing 
this question. 
Addednote: A transformation-related change in the alternative splic- 
ing of p68 has recently been observed. In Swiss 3T3 fibroblasts, pro- 
gression in culture from a normal to a transformed phenotype was ac- 
companied by a change in the ratio of p68 upper band to lower band, 
from 2: 1 to 0.8: 1, as judged by densitometric scanning of 
autoradiographs of [35S]methionine-labelled polypeptides, im- 
munoprecipitated from metabolically labelled cells and separated by 
SDS-PAGE. 
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